Literature DB >> 30323338

Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus.

Max Renner1, Aleksandra Flanagan1, Wanwisa Dejnirattisai2, Chunya Puttikhunt3,4, Watchara Kasinrerk5,6, Piyada Supasa2, Wiyada Wongwiwat2, Kriangkrai Chawansuntati3,4, Thaneeya Duangchinda3, Alison Cowper2, Claire M Midgley2, Prida Malasit3,4, Juha T Huiskonen1, Juthathip Mongkolsapaya7,8, Gavin R Screaton9, Jonathan M Grimes10,11.   

Abstract

Dengue virus is a major pathogen, and severe infections can lead to life-threatening dengue hemorrhagic fever. Dengue virus exists as four serotypes, and dengue hemorrhagic fever is often associated with secondary heterologous infections. Antibody-dependent enhancement (ADE) may drive higher viral loads in these secondary infections and is purported to result from antibodies that recognize dengue virus but fail to fully neutralize it. Here we characterize two antibodies, 2C8 and 3H5, that bind to the envelope protein. Antibody 3H5 is highly unusual as it not only is potently neutralizing but also promotes little if any ADE, whereas antibody 2C8 has strong capacity to promote ADE. We show that 3H5 shows resilient binding in endosomal pH conditions and neutralizes at low occupancy. Immunocomplexes of 3H5 and dengue virus do not efficiently interact with Fcγ receptors, which we propose is due to the binding mode of 3H5 and constitutes the primary mechanism of how ADE is avoided.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30323338      PMCID: PMC7051845          DOI: 10.1038/s41590-018-0227-7

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  63 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

Review 2.  A new generation of the IMAGIC image processing system.

Authors:  M van Heel; G Harauz; E V Orlova; R Schmidt; M Schatz
Journal:  J Struct Biol       Date:  1996 Jan-Feb       Impact factor: 2.867

3.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

4.  Cytotoxicity of a factor isolated from human spleen.

Authors:  C B Lozzio; B B Lozzio
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

5.  Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

Authors:  M K Gentry; E A Henchal; J M McCown; W E Brandt; J M Dalrymple
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

Review 6.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.

Authors:  Maria G Guzman; Mayling Alvarez; Scott B Halstead
Journal:  Arch Virol       Date:  2013-03-08       Impact factor: 2.574

7.  The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.

Authors:  Theodore C Pierson; Qing Xu; Steevenson Nelson; Theodore Oliphant; Grant E Nybakken; Daved H Fremont; Michael S Diamond
Journal:  Cell Host Microbe       Date:  2007-04-19       Impact factor: 21.023

8.  Dengue structure differs at the temperatures of its human and mosquito hosts.

Authors:  Xinzheng Zhang; Ju Sheng; Pavel Plevka; Richard J Kuhn; Michael S Diamond; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-08       Impact factor: 11.205

9.  Decision making in xia2.

Authors:  Graeme Winter; Carina M C Lobley; Stephen M Prince
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-06-18

10.  A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.

Authors:  Guntur Fibriansah; Joanne L Tan; Scott A Smith; Adamberage R de Alwis; Thiam-Seng Ng; Victor A Kostyuchenko; Kristie D Ibarra; Jiaqi Wang; Eva Harris; Aravinda de Silva; James E Crowe; Shee-Mei Lok
Journal:  EMBO Mol Med       Date:  2014-01-13       Impact factor: 12.137

View more
  9 in total

1.  Pathogenic autoantibodies to IFN-γ act through the impedance of receptor assembly and Fc-mediated response.

Authors:  Han-Po Shih; Jing-Ya Ding; Junel Sotolongo Bellón; Yu-Fang Lo; Pei-Han Chung; He-Ting Ting; Jhan-Jie Peng; Tsai-Yi Wu; Chia-Hao Lin; Chia-Chi Lo; You-Ning Lin; Chun-Fu Yeh; Jiun-Bo Chen; Ting-Shu Wu; Yuag-Meng Liu; Chen-Yen Kuo; Shang-Yu Wang; Kun-Hua Tu; Chau Yee Ng; Wei-Te Lei; Yu-Huan Tsai; Jou-Han Chen; Ya-Ting Chuang; Jing-Yi Huang; Félix A Rey; Hung-Kai Chen; Tse-Wen Chang; Jacob Piehler; Chih-Yu Chi; Cheng-Lung Ku
Journal:  J Exp Med       Date:  2022-07-14       Impact factor: 17.579

Review 2.  Discovery of B-cell epitopes for development of dengue vaccines and antibody therapeutics.

Authors:  Mohd Ishtiaq Anasir; Chit Laa Poh
Journal:  Med Microbiol Immunol       Date:  2022-01-21       Impact factor: 3.402

Review 3.  Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development.

Authors:  Vincent Dussupt; Kayvon Modjarrad; Shelly J Krebs
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

4.  The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies.

Authors:  James T Earnest; Autumn C Holmes; Katherine Basore; Matthias Mack; Daved H Fremont; Michael S Diamond
Journal:  Cell Rep       Date:  2021-04-06       Impact factor: 9.423

5.  Immune profile and responses of a novel dengue DNA vaccine encoding an EDIII-NS1 consensus design based on Indo-African sequences.

Authors:  Arun Sankaradoss; Suraj Jagtap; Junaid Nazir; Shefta E Moula; Ayan Modak; Joshuah Fialho; Meenakshi Iyer; Jayanthi S Shastri; Mary Dias; Ravisekhar Gadepalli; Alisha Aggarwal; Manoj Vedpathak; Sachee Agrawal; Awadhesh Pandit; Amul Nisheetha; Anuj Kumar; Mahasweta Bordoloi; Mohamed Shafi; Bhagyashree Shelar; Swathi S Balachandra; Tina Damodar; Moses Muia Masika; Patrick Mwaura; Omu Anzala; Kar Muthumani; Ramanathan Sowdhamini; Guruprasad R Medigeshi; Rahul Roy; Chitra Pattabiraman; Sudhir Krishna; Easwaran Sreekumar
Journal:  Mol Ther       Date:  2022-01-07       Impact factor: 12.910

6.  Designed, highly expressing, thermostable dengue virus 2 envelope protein dimers elicit quaternary epitope antibodies.

Authors:  Stephan T Kudlacek; Stefan Metz; Devina Thiono; Alexander M Payne; Thanh T N Phan; Shaomin Tian; Lawrence J Forsberg; Jack Maguire; Ian Seim; Shu Zhang; Ashutosh Tripathy; Joseph Harrison; Nathan I Nicely; Sandrine Soman; Michael K McCracken; Gregory D Gromowski; Richard G Jarman; Lakshmanane Premkumar; Aravinda M de Silva; Brian Kuhlman
Journal:  Sci Adv       Date:  2021-10-15       Impact factor: 14.136

Review 7.  Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?

Authors:  Lucas Wilken; Guus F Rimmelzwaan
Journal:  Pathogens       Date:  2020-06-15

8.  Structures of enveloped virions determined by cryogenic electron microscopy and tomography.

Authors:  Robert Stass; Weng M Ng; Young Chan Kim; Juha T Huiskonen
Journal:  Adv Virus Res       Date:  2019-08-20       Impact factor: 9.937

9.  Flavivirus maturation leads to the formation of an occupied lipid pocket in the surface glycoproteins.

Authors:  Max Renner; Wanwisa Dejnirattisai; Loïc Carrique; Itziar Serna Martin; Dimple Karia; Serban L Ilca; Shu F Ho; Abhay Kotecha; Jeremy R Keown; Juthathip Mongkolsapaya; Gavin R Screaton; Jonathan M Grimes
Journal:  Nat Commun       Date:  2021-02-23       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.